Post COVID stocks to watch
2 minute read
This week, the Australian Bureau of Statistics released some good economic data regarding our economy, reporting GPD growth of 1.8 per cent for the March quarter, which is ahead of expectations and much better than many other countries.
With vaccines rolling out across the world, everyone is looking towards 2022 where it is expected that life will return to something more akin to normal. So, which stocks will benefit as the Australia market and the world opens again and which stocks are likely to continue to struggle?
It is likely that commercial real estate and shopping centres will continue to struggle, as we are now in the habit of working and shopping from home, therefore, in the next 12 months stocks such as Scentre Group and Vicinity Centres are unlikely to perform given that a lot of stores have closed while other businesses may be very hesitant to open up new stores.
Travel stocks are also likely to underperform at least until mid-2022, given that restrictions around international travel are unlikely to change until well into next year.
On a positive note, online retailers should continue to do well and with less expenditure on overseas travel, Australians will continue spend on items in Australia with JB Hifi, Kogan and Harvey Norman likely to be the winners.
Australians are also more likely to favour driving holidays and weekends away over the next 12 months.
Therefore, retailers involved in caravan, camping, sporting goods, four-wheel driving and other leisure activities are likely to do well, especially as we move into summer later this year.
Another area that is likely to benefit is companies that are being supported by growing revenues from offshore such as ResMed, Aristocrat Leisure and even the troubled Treasury Wines Estates to name a few.
I will say, one thing that is guaranteed as we move closer to 2022 and that is the economy will continue to change and shift to a new way of living.
Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also the author of the award-winning book Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in all good book stores and online at www.wealthwithin.com.au
NB: Neither Dale or Wealth Within are affiliated with any of our related portfolios.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.